Chronic Pain Protocol: Ketamine for Fibromyalgia and Migraines

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

Ketamine's FDA-approved indications are anesthesia and treatment-resistant depression. Its off-label use for chronic pain is one of the most evidence-supported applications in the field, and it's where some of the earliest ketamine research outside anesthesia was conducted. For patients with fibromyalgia, refractory migraines, complex regional pain syndrome, or other centrally mediated pain conditions, ketamine represents a mechanism that conventional pain medicine simply doesn't offer.

I'm Dr. Farhan Abdullah at Magnolia Functional Wellness in Southlake.

Why Chronic Pain Is a Brain Problem, Not Just a Body Problem

Acute pain is protective -- it signals tissue damage and motivates avoidance of the damaging stimulus. Chronic pain has lost that signal function and become a disease process in its own right. In conditions like fibromyalgia and chronic migraine, the central nervous system has undergone sensitization: pain processing pathways have been upregulated such that stimuli that wouldn't normally produce pain do so, and stimuli that would produce mild pain produce severe pain. This is called central sensitization, and it's the mechanism behind the disproportionate, widespread pain in fibromyalgia and the progressive lowering of migraine threshold in chronic sufferers.

Central sensitization involves NMDA receptor overactivation in spinal cord and brain pain circuits. The glutamatergic system becomes hyperexcitable, maintaining pain signaling long after any initial injury has resolved. This is where ketamine's mechanism becomes directly relevant.

How Ketamine Addresses Central Sensitization

Ketamine's NMDA antagonism directly inhibits the receptor type whose overactivation drives central sensitization. By blocking NMDA receptors in pain circuits, ketamine interrupts the pathological amplification loop that maintains chronic pain. This isn't temporary suppression -- there's evidence that ketamine infusions can produce lasting "resetting" of sensitized pain circuits, with pain relief that extends well beyond the duration of the drug in the system.

Ketamine also affects mu-opioid receptors and interacts with sodium channels, providing additional analgesic mechanisms that complement the NMDA effect. For patients who have been managed with opioids with diminishing returns, ketamine works through entirely different pathways and can produce relief where opioids have failed.

Fibromyalgia and Ketamine

Fibromyalgia is one of the conditions with the most compelling evidence for ketamine's analgesic effects. Multiple controlled studies have shown significant, sustained pain reduction following ketamine infusion protocols in fibromyalgia patients -- with some studies showing meaningful relief lasting weeks to months from a single infusion series. The widespread, allodynic nature of fibromyalgia pain maps directly onto the central sensitization mechanism that ketamine addresses.

Migraine and Ketamine

For refractory chronic migraine -- patients with 15 or more migraine days per month who haven't responded adequately to preventive medications -- ketamine infusion protocols have shown meaningful efficacy in breaking prolonged migraine cycles and reducing overall frequency. The mechanism involves NMDA-mediated cortical spreading depression interruption and modulation of trigeminovascular pain processing. Several headache centers now include ketamine infusion as a treatment option for status migrainosus and refractory chronic migraine.

What Treatment Looks Like

Chronic pain protocols in our ketamine therapy program in Southlake typically involve a series of infusions over one to two weeks, with the dose and infusion duration calibrated differently than psychiatric indications -- pain protocols often use lower doses over longer periods. Repeat infusion series may be needed at intervals of several months depending on the duration of response. The goal is sustained pain reduction that improves quality of life and reduces dependence on other pain medications, not elimination of all pain in every patient.

If you've been managing fibromyalgia or chronic migraines with medications that provide partial relief at best, ketamine is one of the most mechanistically rational options available -- and one of the most underutilized in pain management.